Designer drugs in the general hospital (Q77818333)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912942%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Designer drugs in the general hospital (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912942%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Philip A Bialer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912942%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912942%20AND%20SRC:MED&resulttype=core&format=json

Psychiatric Clinics of North America

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912942%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912942%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912942%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

231-243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912942%20AND%20SRC:MED&resulttype=core&format=json

A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration.

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Ecstasy: a common cause of severe acute hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Amphetamine use: return of an old scourge in a consultation psychiatry setting

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Memory impairment in abstinent MDMA ("Ecstasy") users

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Clinical course of gamma-hydroxybutyrate overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Severe gamma-hydroxybutyrate withdrawal: a case report and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Illicit use of ketamine in Scotland.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Clinical experience with oral ketamine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Myocardial infarction after intranasal methamphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Physical dependence on sodium oxybate.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

The serotonin syndrome and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Fatal interaction between ritonavir and MDMA

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

GHB-induced delirium: a case report and review of the literature of gamma hydroxybutyric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Acute toxicity from home-brewed gamma hydroxybutyrate.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Coma and respiratory depression following the ingestion of GHB and its precursors: three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-2001. A 17-year-old girl with marked jaundice and weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Gamma-hydroxybutyric acid: an emerging recreational drug

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

gamma-Hydroxybutyrate intoxication and overdose.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

1 reference

7 January 2021

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Methamphetamine psychosis: spontaneous recurrence of paranoid-hallucinatory states and monoamine neurotransmitter function

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Olanzapine treatment of methamphetamine psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

A tale of novel intoxication: seven cases of gamma-hydroxybutyric acid overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Gamma-hydroxy butyrate withdrawal delirium: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Ecstasy--long-term effects on the human central nervous system revealed by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Use of anticonvulsants in benzodiazepine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

A pilot open randomized trial of valproate and phenobarbital in the treatment of acute alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

1 reference

7 January 2021

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

Adverse events, including death, associated with the use of 1,4-butanediol

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900060-1

7 January 2021

10.1016/S0193-953X(03)00060-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11912942%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference